Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-045045

President and CEO sold 3,722 shares at $1.72 ($6,402)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-07 Sale : show line 1 in the form 10b5-1 −3,722 $1.72 $6,402 802,018 D
Open-market sales · 3,722 sh · avg $1.72 · $6,402
Loading xslF345X05/doc4.xml…